2509-4254

PharmacoEconomics - Open

Springer-Verlag

View prefix report (10.1007)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 649 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact649 DOIs
2

Attach ORCID iDs across 159 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact159 DOIs
3

Deposit reference lists for 40 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact40 DOIs

DOIs for this ISSN

Showing the top 5 of 662 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Similarities and Differences in Health Technology Assessment… (10.1007/s41669-021-00311-5)
Abstract ORCID
94.32 76
2 Health Technology Assessment for Policy Making in India: Cur… (10.1007/s41669-017-0037-0)
Abstract ORCID
91.30 66
3 A Nationwide Study of Prevalence Rates and Characteristics o… (10.1007/s41669-019-0167-7)
Abstract ORCID
90.65 64
4 Functional Status and Well-Being in People with Myalgic Ence… (10.1007/s41669-018-0071-6)
Abstract ORCID
89.62 61
5 A Systematic Review of Time and Resource Use Costs of Subcut… (10.1007/s41669-022-00361-3)
Abstract ORCID
87.41 55
6 Handling Missing Data in Within-Trial Cost-Effectiveness Ana… (10.1007/s41669-017-0015-6)
Abstract ORCID
82.66 44
7 Risk-Sharing Agreements in the EU: A Systematic Review of Ma… (10.1007/s41669-017-0044-1)
Abstract ORCID
81.16 41
8 Mixture Cure Models in Oncology: A Tutorial and Practical Gu… (10.1007/s41669-021-00260-z)
Abstract ORCID
79.55 38
9 Direct Medical Costs of Type 2 Diabetes in France: An Insura… (10.1007/s41669-017-0050-3)
Abstract ORCID
78.41 36
10 The Health System Costs of Potentially Inappropriate Prescri… (10.1007/s41669-019-0143-2)
Abstract ORCID
77.20 34
11 Early Assessment of the Likely Cost Effectiveness of Single-… (10.1007/s41669-017-0012-9)
Abstract ORCID
76.57 33
12 Cost of Intensive Care Treatment for Liver Disorders at Tert… (10.1007/s41669-017-0041-4)
Abstract ORCID
75.93 32
13 Evaluating the Treatment Costs for Uncomplicated Malaria at… (10.1007/s41669-017-0021-8)
Abstract ORCID
75.26 31
14 Person-Centred Care in Patients with Acute Coronary Syndrome… (10.1007/s41669-019-0126-3)
Abstract ORCID
74.57 30
15 National Health Insurance Databases in Indonesia, Vietnam an… (10.1007/s41669-019-0127-2)
Abstract ORCID
74.57 30
16 A Single-Center Cost Analysis of Treating Primary and Metast… (10.1007/s41669-016-0003-2)
Abstract ORCID
73.86 29
17 The Healthcare Cost Burden of Acute Myocardial Infarction in… (10.1007/s41669-017-0061-0)
Abstract ORCID
73.86 29
18 Assessing Variation in the Cost of Palivizumab for Respirato… (10.1007/s41669-017-0042-3)
Abstract ORCID
73.12 28
19 Utilization, Spending, and Price Trends for Quinolones in th… (10.1007/s41669-016-0007-y)
Abstract ORCID
70.75 25
20 The Cost of Patients with Chronic Kidney Failure Before Dial… (10.1007/s41669-017-0062-z)
Abstract ORCID
69.90 24
21 Check Your Checklist: The Danger of Over- and Underestimatin… (10.1007/s41669-019-0118-3)
Abstract ORCID
69.01 23
22 Impact of Plan-Level Access Restrictions on Effectiveness of… (10.1007/s41669-019-0152-1)
Abstract ORCID
69.01 23
23 Uterotonic Drugs for the Prevention of Postpartum Haemorrhag… (10.1007/s41669-018-0108-x)
Abstract ORCID
68.09 22
24 Cenegermin for Treating Neurotrophic Keratitis: An Evidence… (10.1007/s41669-019-0138-z)
Abstract ORCID
68.09 22
25 Comparison of Disease-Modifying Therapies for the Management… (10.1007/s41669-017-0035-2)
Abstract ORCID
67.12 21
26 Health-Related Quality of Life in Patients Treated with Cont… (10.1007/s41669-017-0046-z)
Abstract ORCID
67.12 21
27 Economic Burden of Chronic Obstructive Pulmonary Disease Pat… (10.1007/s41669-020-00214-x)
Abstract ORCID
67.12 21
28 High Healthcare Resource Use in Hospitalized Patients with a… (10.1007/s41669-018-0093-0)
Abstract ORCID
66.11 20
29 Cost-Effectiveness Analysis of Ofatumumab for the Treatment… (10.1007/s41669-022-00363-1)
Abstract ORCID
66.11 20
30 Cost-Benefit Analysis of Telemedicine Systems/Units in Greek… (10.1007/s41669-016-0006-z)
Abstract ORCID
65.05 19
31 The Potential Cost-Effectiveness of HIV Vaccines: A Systemat… (10.1007/s41669-016-0009-9)
Abstract ORCID
65.05 19
32 Reliability and Validity of the Greek Migraine Disability As… (10.1007/s41669-017-0034-3)
Abstract ORCID
65.05 19
33 Value Assessment Frameworks in the United States: A Call for… (10.1007/s41669-018-0094-z)
Abstract ORCID
65.05 19
34 A Review of Issues Affecting the Efficiency of Decision Maki… (10.1007/s41669-018-0113-0)
Abstract ORCID
65.05 19
35 Estimation of the Incremental Cumulative Cost of HIV Compare… (10.1007/s41669-020-00209-8)
Abstract ORCID
65.05 19
36 Empirical Monetary Valuation of a Quality-Adjusted Life-Year… (10.1007/s41669-020-00211-0)
Abstract ORCID
65.05 19
37 Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy wi… (10.1007/s41669-019-00178-7)
Abstract ORCID
63.94 18
38 Can We Accurately Predict Cost Effectiveness Without Access… (10.1007/s41669-018-0080-5)
Abstract ORCID
62.76 17
39 Adherence, Healthcare Resource Utilization, and Costs in Med… (10.1007/s41669-018-0089-9)
Abstract ORCID
62.76 17
40 Treatment Satisfaction and Burden of Illness in Patients wit… (10.1007/s41669-019-00184-9)
Abstract ORCID
62.76 17
41 An Exploratory Study: A Head-to-Head Comparison of the EQ-5D… (10.1007/s41669-017-0060-1)
Abstract ORCID
61.52 16
42 Economic Burden of Patients Treated for Higher-Risk Myelodys… (10.1007/s41669-018-0100-5)
Abstract ORCID
61.52 16
43 Economic Evaluation of Fulvestrant 500 mg Compared to Generi… (10.1007/s41669-017-0031-6)
Abstract ORCID
58.80 14
44 The Economic Burden of Small Cell Lung Cancer: A Systematic… (10.1007/s41669-017-0045-0)
Abstract ORCID
58.80 14
45 A Retrospective Claims Analysis of Advanced Prostate Cancer… (10.1007/s41669-019-00185-8)
Abstract ORCID
58.80 14
46 Systematic Review of Economic Evaluations in Primary Open-An… (10.1007/s41669-019-0141-4)
Abstract ORCID
58.80 14
47 Real-World Treatment Patterns, Outcomes, Resource Utilizatio… (10.1007/s41669-021-00306-2)
Abstract ORCID
58.80 14
48 The Potential Clinical and Economic Value of Primary Tumour… (10.1007/s41669-017-0051-2)
Abstract ORCID
57.31 13
49 Healthcare Cost Development in a Type 2 Diabetes Patient Pop… (10.1007/s41669-017-0063-y)
Abstract ORCID
57.31 13
50 Economic Burden of Delayed Diagnosis in Patients with Pulmon… (10.1007/s41669-023-00453-8)
Abstract ORCID
57.31 13